Parameters |
Findings |
Findings |
Remarks |
Anti Neutrophil Cytoplasmic Antibodies (IFA) |
Anti
Neutrophil Cytoplasmic Antibodies (IFA) |
Anti Neutrophil
Cytoplasmic Antibodies (IFA) |
Anti Neutrophil Cytoplasmic
Antibodies (IFA) |
c-ANCA |
c-ANCA |
1.37 U/ml |
Negative |
p-ANCA |
p-ANCA |
- |
Negative |
Fluorescent In situ hybridization (FISH)- Eosinophilic Leukemia
Panel |
Fluorescent In situ hybridization (FISH)- Eosinophilic
Leukemia Panel |
Fluorescent In situ hybridization (FISH)-
Eosinophilic Leukemia Panel |
Fluorescent In situ hybridization
(FISH)- Eosinophilic Leukemia Panel |
PDGFRA rearrangement (4q12) |
PDGFRA rearrangement (4q12) |
0 |
Negative |
PDGFRB rearrangement (5q33) |
PDGFRB rearrangement (5q33) |
0 |
Negative |
FGFR1 rearrangement (8p11.22-11.23) |
FGFR1 rearrangement
(8p11.22-11.23) |
0 |
Negative |
CBFB rearrangement (Inv 16) |
CBFB rearrangement (Inv 16) |
0 |
Negative |
Bone marrow examination |
Bone marrow examination |
Bone marrow examination |
Bone marrow
examination |
Cellularity |
Cellularity |
Hypercellular |
|
Erythroid series |
Erythroid series |
Present with normoblastic
maturation |
|
Myeloid series |
Myeloid series |
Increased with progressive maturation
up to neutrophils. Markedly increased eosinophils and precursors were
noted, which show dysplasia in the form of abnormal segmentation and
irregular distribution of granules. |
Myeloid hyperplasia |